IL149598A0 - Placental human neurokinin b precursor - Google Patents

Placental human neurokinin b precursor

Info

Publication number: IL149598A0
Authority: IL; Israel
Prior art keywords: precursor; methods; human neurokinin; neurokinin; placental human
Prior art date: 1999-11-16

Application number

IL14959800A

Other languages

English (en)

Original Assignee

Univ Reading

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-16

Filing date

2000-11-10

Publication date

2002-11-10

2000-11-10 Application filed by Univ Reading filed Critical Univ Reading

2002-11-10 Publication of IL149598A0 publication Critical patent/IL149598A0/xx

Links

239000002243 precursor Substances 0.000 title abstract 2
101500027535 Homo sapiens Neurokinin-B Proteins 0.000 title 1
230000003169 placental effect Effects 0.000 title 1
238000000034 method Methods 0.000 abstract 3
206010070538 Gestational hypertension Diseases 0.000 abstract 1
201000005624 HELLP Syndrome Diseases 0.000 abstract 1
NHXYSAFTNPANFK-HDMCBQFHSA-N Neurokinin B Chemical compound C([C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC(O)=O)C1=CC=CC=C1 NHXYSAFTNPANFK-HDMCBQFHSA-N 0.000 abstract 1
102000046798 Neurokinin B Human genes 0.000 abstract 1
101800002813 Neurokinin-B Proteins 0.000 abstract 1
208000005347 Pregnancy-Induced Hypertension Diseases 0.000 abstract 1
230000000890 antigenic effect Effects 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
238000005259 measurement Methods 0.000 abstract 1
201000011461 pre-eclampsia Diseases 0.000 abstract 1
208000036335 preeclampsia/eclampsia 1 Diseases 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/046—Tachykinins, e.g. eledoisins, substance P; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2410/00—Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Analytical Chemistry (AREA)
Pathology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Physics & Mathematics (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Biochemistry (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Food Science & Technology (AREA)
Reproductive Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Gynecology & Obstetrics (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Pregnancy & Childbirth (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

IL14959800A 1999-11-16 2000-11-10 Placental human neurokinin b precursor IL149598A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9927125.6A GB9927125D0 (en)	1999-11-16	1999-11-16	Placental human neurokinin B precursor
PCT/GB2000/004315 WO2001036979A2 (en)	1999-11-16	2000-11-10	Placental human neurokinin b precursor

Publications (1)

Publication Number	Publication Date
IL149598A0 true IL149598A0 (en)	2002-11-10

Family

ID=10864633

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL14959800A IL149598A0 (en)	1999-11-16	2000-11-10	Placental human neurokinin b precursor

Country Status (15)

Country	Link
US (1)	US7947458B1 (de)
EP (1)	EP1229965B1 (de)
JP (1)	JP4668501B2 (de)
CN (1)	CN1414871A (de)
AT (1)	ATE299739T1 (de)
AU (1)	AU778423B2 (de)
CA (1)	CA2391531A1 (de)
DE (1)	DE60021409T2 (de)
ES (1)	ES2244480T3 (de)
GB (1)	GB9927125D0 (de)
IL (1)	IL149598A0 (de)
NO (1)	NO330412B1 (de)
NZ (1)	NZ519283A (de)
WO (1)	WO2001036979A2 (de)
ZA (1)	ZA200203880B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6919433B2 (en)	1997-03-14	2005-07-19	Human Genome Sciences, Inc.	Antibodies to protein HPMBQ91
EP1333092A3 (de) *	1997-03-14	2003-12-10	Human Genome Sciences, Inc.	28 menschlich sekretierte Proteine
US20240336565A1 (en)	2021-07-02	2024-10-10	Acer Therapeutics, Inc.	Solid forms of osanetant

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4665157A (en)	1985-09-30	1987-05-12	Mcneilab, Inc.	Peptide antagonists of neurokinin B
US4742156A (en) *	1985-09-30	1988-05-03	Mcneilab, Inc.	Peptide antagonists of neurokinin B and opthalmic solutions containing them
US5331089A (en)	1988-03-25	1994-07-19	Merck Sharpe & Dohme, Ltd.	Peptides useful as tachykinin agonists
US5079171A (en) *	1988-09-15	1992-01-07	Adeza Biomedical Corporation	Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin
ES2149767T5 (es)	1991-09-20	2005-06-16	Glaxo Group Limited	Nuevo uso medico para antagonistas de taquiquininas.
US5328927A (en)	1992-03-03	1994-07-12	Merck Sharpe & Dohme, Ltd.	Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them
AU4713293A (en)	1992-07-13	1994-01-31	Merck Sharp & Dohme Limited	Heterocyclic amide derivatives as tachykinin derivatives
CA2140640A1 (en)	1992-08-13	1994-03-03	David C. Horwell	Tachykinin antagonists
US5922681A (en) *	1992-09-14	1999-07-13	Warner-Lambert Company	Endothelin antagonists
FR2696178B1 (fr)	1992-09-30	1994-12-30	Sanofi Elf	Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant.
US5344830A (en)	1992-12-10	1994-09-06	Merck & Co., Inc.	N,N-diacylpiperazine tachykinin antagonists
US5543138A (en) *	1994-03-10	1996-08-06	Genetics Institute, Inc.	Methods of diagnosing and treating preeclampsia
FR2719311B1 (fr) *	1994-03-18	1998-06-26	Sanofi Sa	Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
US5491140A (en)	1994-06-30	1996-02-13	Eli Lilly And Company	Naphthyl tachykinin receptor antagonists to treat physiological conditions
AU688072B2 (en)	1994-07-12	1998-03-05	Eli Lilly And Company	Heterocyclic tachykinin receptor antagonists
CA2154116A1 (en)	1994-07-22	1996-01-23	Philip Arthur Hipskind	1-aryl-2-acetamidopentanone derivatives for use as tachykinin receptor antagonists
EP0912178A4 (de) *	1996-05-24	2000-08-16	Lilly Co Eli	Verfahren zur behandlung des bluthochdrucks
GB9618931D0 (en) *	1996-09-11	1996-10-23	Univ London	Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
US5846973A (en)	1997-05-23	1998-12-08	Eli Lilly And Company	Methods of treating pulmonary hypertension
US5985606A (en) *	1997-06-19	1999-11-16	Incyte Pharmaceuticals, Inc.	Human preprotachykinin B
CA2236489A1 (en) *	1997-07-14	1999-01-14	Human Genome Sciences	Novel compounds
EP0892053A3 (de) *	1997-07-14	1999-12-29	Smithkline Beecham Plc	Herstellung von rekombinantem HPMBQ91 Polypeptide und dessen Verwendungen
US6689566B1 (en) *	1999-01-14	2004-02-10	Scantibodies Laboratory, Inc.	Methods, kits, and antibodies for detecting parathyroid hormone

1999
- 1999-11-16 GB GBGB9927125.6A patent/GB9927125D0/en not_active Ceased
2000
- 2000-11-10 WO PCT/GB2000/004315 patent/WO2001036979A2/en not_active Ceased
- 2000-11-10 AT AT00974680T patent/ATE299739T1/de not_active IP Right Cessation
- 2000-11-10 US US10/130,340 patent/US7947458B1/en not_active Expired - Fee Related
- 2000-11-10 CN CN00818115A patent/CN1414871A/zh active Pending
- 2000-11-10 EP EP00974680A patent/EP1229965B1/de not_active Expired - Lifetime
- 2000-11-10 DE DE60021409T patent/DE60021409T2/de not_active Expired - Lifetime
- 2000-11-10 JP JP2001538816A patent/JP4668501B2/ja not_active Expired - Fee Related
- 2000-11-10 CA CA002391531A patent/CA2391531A1/en not_active Abandoned
- 2000-11-10 NZ NZ519283A patent/NZ519283A/en not_active IP Right Cessation
- 2000-11-10 IL IL14959800A patent/IL149598A0/xx unknown
- 2000-11-10 AU AU12898/01A patent/AU778423B2/en not_active Ceased
- 2000-11-10 ES ES00974680T patent/ES2244480T3/es not_active Expired - Lifetime
2002
- 2002-05-14 NO NO20022276A patent/NO330412B1/no not_active IP Right Cessation
- 2002-05-15 ZA ZA200203880A patent/ZA200203880B/xx unknown

Also Published As

Publication number	Publication date
EP1229965A2 (de)	2002-08-14
ES2244480T3 (es)	2005-12-16
WO2001036979A3 (en)	2002-05-02
DE60021409T2 (de)	2006-05-24
ZA200203880B (en)	2003-08-15
NO20022276D0 (no)	2002-05-14
CA2391531A1 (en)	2001-05-25
AU778423B2 (en)	2004-12-02
WO2001036979A2 (en)	2001-05-25
EP1229965B1 (de)	2005-07-20
NO20022276L (no)	2002-07-05
DE60021409D1 (de)	2005-08-25
GB9927125D0 (en)	2000-01-12
ATE299739T1 (de)	2005-08-15
AU1289801A (en)	2001-05-30
CN1414871A (zh)	2003-04-30
JP2003515138A (ja)	2003-04-22
NZ519283A (en)	2004-05-28
NO330412B1 (no)	2011-04-11
US7947458B1 (en)	2011-05-24
JP4668501B2 (ja)	2011-04-13

Publication	Publication Date	Title
IL127558A0 (en)	1999-10-28	Hepatocyte growth factor receptor agonists and uses thereof
EP1470146B8 (de)	2007-09-12	Antikörper gegen das muc18-antigen
AU3878697A (en)	1998-02-02	Identification of abnormalities in the expression of t and cell antigen receptors as indicators of disease diagnosis, prognosis and therapeutic predictors
WO2001034801A3 (en)	2002-01-31	Recombinant gelatin in vaccines
WO1997008318A3 (en)	1997-04-17	Compounds and methods for treatment and diagnosis of prostate cancer
WO2003057006A3 (en)	2003-09-04	Use of antibodies against the muc18 antigen
WO2003057837A8 (en)	2003-10-30	Methods for using anti-muc18 antibodies
HUP0103758A2 (hu)	2002-01-28	Neurotróf faktorok
PL343245A1 (en)	2001-07-30	Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses
PT1056856E (pt)	2002-07-31	Factor neurotrofico cliliar modificado processo de preparacao e sua utilizacao
BRPI9912227B8 (pt)	2021-07-06	método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método.
ES2293973T3 (es)	2008-04-01	Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
MXPA02011656A (es)	2004-07-30	Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
DE3750389D1 (de)	1994-09-22	Antikörper gegen menschlichen progesteronrezeptor sowie diagnosematerial und -verfahren.
BG101024A (bg)	1997-09-30	Моноклонално антитяло срещу сd44v6
NO971341D0 (no)	1997-03-21	Promoter for reseptor tyrosinkinase TIE
ATE181422T1 (de)	1999-07-15	Verfahren zur diagnose von praeklampsie
WO2000058475A3 (en)	2001-03-08	Streptococcus pneumoniae antigens
WO2004018995A3 (en)	2004-09-10	Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibodies and other binding agents
ZA200203880B (en)	2003-08-15	Placental human neurokinin B precursor.
ATE514780T1 (de)	2011-07-15	Zusammensetzungen für die therapie und diagnose von brustkrebs und verwendung davon
NO993653D0 (no)	1999-07-27	Fremgangsmåte for diagnose, prognose og behandling av glaukom og relaterte sykdommer
IT1307864B1 (it)	2001-11-19	Metodo diagnostico per il riconoscimento di neoplasie umane attraversola determinazione dell'isoforma ctn-c della tn-c, frammenti di
WO2004032599A3 (en)	2004-07-15	Novel immunogenic proteins of leptospira
AU2001280368A1 (en)	2002-02-18	Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotherapy